Serotype Distribution of Streptococcus pneumoniae causing Invasive Pneumococcal Disease at Bambino Gesù Children's Hospital in Rome: Is It Time for a New Vaccine?

Luciana Nicolosi, Elena Bozzola, Andrzej Krzysztofiak, Annausa Pantosti, Laura Lancella, Paola Bernaschi, Maria Rosaria Marchili, Alberto Villani

Research output: Contribution to journalArticle

Abstract

Diseases caused by Streptococcus pneumoniae are mostly preventable infections by current immunization programs. The objective of this study was to evaluate the impact of the introduction of the heptavalent and the 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) on the burden of pneumococcal disease and on the serotype distribution of S. pneumoniae causing invasive pneumococcal diseases (IPDs) in the pediatric age over a 5-year study (from January 2008 till December 2012). We observed a decrease in IPD rate in children after PCV13 introduction despite increases in nonvaccine serotype (NVS) rates in 2011. Nevertheless, from 2012, an increase in IPD rates due to non-PCV13 serotypes was observed.

Original languageEnglish
JournalJournal of Pediatric Infectious Diseases
DOIs
Publication statusAccepted/In press - Jan 2 2018

Fingerprint

Streptococcus pneumoniae
Vaccines
Immunization Programs
Conjugate Vaccines
Serogroup
Pediatrics
Infection

Keywords

  • children
  • invasive disease
  • Streptococcus pneumoniae
  • vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases

Cite this

@article{ed375717bc7348de8100ddb508f8aed6,
title = "Serotype Distribution of Streptococcus pneumoniae causing Invasive Pneumococcal Disease at Bambino Ges{\`u} Children's Hospital in Rome: Is It Time for a New Vaccine?",
abstract = "Diseases caused by Streptococcus pneumoniae are mostly preventable infections by current immunization programs. The objective of this study was to evaluate the impact of the introduction of the heptavalent and the 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) on the burden of pneumococcal disease and on the serotype distribution of S. pneumoniae causing invasive pneumococcal diseases (IPDs) in the pediatric age over a 5-year study (from January 2008 till December 2012). We observed a decrease in IPD rate in children after PCV13 introduction despite increases in nonvaccine serotype (NVS) rates in 2011. Nevertheless, from 2012, an increase in IPD rates due to non-PCV13 serotypes was observed.",
keywords = "children, invasive disease, Streptococcus pneumoniae, vaccine",
author = "Luciana Nicolosi and Elena Bozzola and Andrzej Krzysztofiak and Annausa Pantosti and Laura Lancella and Paola Bernaschi and Marchili, {Maria Rosaria} and Alberto Villani",
year = "2018",
month = "1",
day = "2",
doi = "10.1055/s-0037-1615784",
language = "English",
journal = "Journal of Pediatric Infectious Diseases",
issn = "1871-0336",
publisher = "IOS Press",

}

TY - JOUR

T1 - Serotype Distribution of Streptococcus pneumoniae causing Invasive Pneumococcal Disease at Bambino Gesù Children's Hospital in Rome

T2 - Is It Time for a New Vaccine?

AU - Nicolosi, Luciana

AU - Bozzola, Elena

AU - Krzysztofiak, Andrzej

AU - Pantosti, Annausa

AU - Lancella, Laura

AU - Bernaschi, Paola

AU - Marchili, Maria Rosaria

AU - Villani, Alberto

PY - 2018/1/2

Y1 - 2018/1/2

N2 - Diseases caused by Streptococcus pneumoniae are mostly preventable infections by current immunization programs. The objective of this study was to evaluate the impact of the introduction of the heptavalent and the 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) on the burden of pneumococcal disease and on the serotype distribution of S. pneumoniae causing invasive pneumococcal diseases (IPDs) in the pediatric age over a 5-year study (from January 2008 till December 2012). We observed a decrease in IPD rate in children after PCV13 introduction despite increases in nonvaccine serotype (NVS) rates in 2011. Nevertheless, from 2012, an increase in IPD rates due to non-PCV13 serotypes was observed.

AB - Diseases caused by Streptococcus pneumoniae are mostly preventable infections by current immunization programs. The objective of this study was to evaluate the impact of the introduction of the heptavalent and the 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) on the burden of pneumococcal disease and on the serotype distribution of S. pneumoniae causing invasive pneumococcal diseases (IPDs) in the pediatric age over a 5-year study (from January 2008 till December 2012). We observed a decrease in IPD rate in children after PCV13 introduction despite increases in nonvaccine serotype (NVS) rates in 2011. Nevertheless, from 2012, an increase in IPD rates due to non-PCV13 serotypes was observed.

KW - children

KW - invasive disease

KW - Streptococcus pneumoniae

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85040046834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040046834&partnerID=8YFLogxK

U2 - 10.1055/s-0037-1615784

DO - 10.1055/s-0037-1615784

M3 - Article

AN - SCOPUS:85040046834

JO - Journal of Pediatric Infectious Diseases

JF - Journal of Pediatric Infectious Diseases

SN - 1871-0336

ER -